The following are key points to remember from a state-of-the-art review on multimodality imaging in the diagnostic work-up of patients with cardiac masses: ...

Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode three of four, Ms. Amy Brownell will interview Ms. Corrin McCloskey and Dr. Joseph Goeke on developing a ...

Women with hypertensive disorders of pregnancy (HDP) have greater odds of having ACS in the future. Furthermore, pregnancy with HDP significantly increased the risk of a higher SYNTAX score, a marker ...

This observational study reports that transseptal MViV with SAPIEN 3/SAPIEN 3 Ultra was associated with excellent procedural outcomes, low complication rates, significant improvement in valve ...

The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (PFS) final rule on Nov. 1. Of note, the 2025 PFS conversion factor is $32.3465, reduced 2.83% ...

Breast cancer survivors who develop HF or MI face a four-fold increased risk of cancer-related death. HF shows stronger associations with adverse oncologic outcomes compared to MI alone. Findings ...

In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients. He then explores the comparative effectiveness and safety ...

The following are key points to remember from a state-of-the-art review on treatment options for patients with secondary mitral regurgitation (SMR): ...

Anam Waheed, MD, FACC, spoke with Ron Blankstein, MD, FACC, about leadership, education and advocacy in the cardiovascular imaging field. Blankstein is a professor of Medicine and Radiology at Harvard ...

IVL TAVR was associated with a higher rate of the primary composite outcome driven by a higher rate of vascular complications, surgical vascular intervention, and major bleeding compared to non-IVL ...

Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of ...

In this special edition of Eagle’s Eye View, Dr. Eagle looks four of the most important trials presented at the recent TCT Conference: 1) EARLY TAVR evaluating TAVR compared to clinical surveillance; ...